Nissan North America, Inc.
Summary
NHTSA campaign 25V153: Nissan North America, Inc. recalled for a safety defect. An unsecured driver's seat may not adequately restrain the driver during a crash, increasing the risk of injury.
Details
Source
nhtsa
External ID
25V153
Action Date
2025-03-12
Status
Ongoing
Category
vehicle
Product Description
Nissan North America, Inc. (Nissan) is recalling certain 2025 Sentra vehicles. The driver's seat frame may not be fully secured to the outer side of the seat track. As such, these vehicles fail to comply with the requirements of Federal Motor Vehicle Safety Standard numbers 207, "Seating Systems," and 210, "Seat Belt Assembly Anchorages."
Company
Context & Analysis
Nissan North America, Inc. has 85 FDA actions in our database.
Frequently Asked Questions
How often does Nissan North America, Inc. have FDA actions?
Nissan North America, Inc. has 85 FDA actions in our database, including 0 recalls and 0 device clearances.
Where can I find the official FDA record?
The official record is available on FDA.gov. Use the link above to view the complete official filing. You can also use the openFDA API to query this record programmatically.
Want to know the moment something like this happens?
Get alerts for vehicle